ZA9811174B - New crystalline form of omeprazole. - Google Patents

New crystalline form of omeprazole.

Info

Publication number
ZA9811174B
ZA9811174B ZA9811174A ZA9811174A ZA9811174B ZA 9811174 B ZA9811174 B ZA 9811174B ZA 9811174 A ZA9811174 A ZA 9811174A ZA 9811174 A ZA9811174 A ZA 9811174A ZA 9811174 B ZA9811174 B ZA 9811174B
Authority
ZA
South Africa
Prior art keywords
methoxy
crystalline form
omeprazole
methylüsulfinylü
benzimidazole
Prior art date
Application number
ZA9811174A
Other languages
English (en)
Inventor
Karin Loevqvist
David Noreland
Gunnel Sunden
Ingvar Ymen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27543202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9811174(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9811174B publication Critical patent/ZA9811174B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9811174A 1998-11-10 1998-12-07 New crystalline form of omeprazole. ZA9811174B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE29823393U DE29823393U1 (de) 1998-11-10 1998-11-10 Neue kristalline Form von Omeprazol
BR9816067-2A BR9816067A (pt) 1998-11-10 1998-11-10 Forma a de omeprazol, omeprazol, processo para a preparação da forma a de omeprazol, formulação farmacêutica, uso de omeprazol, e, método de tratamento de distúrbios gastrointestinais.
PCT/SE1998/002028 WO1999008500A2 (fr) 1998-11-10 1998-11-10 Nouvelle forme cristalline d'omeprazole
EP98957255A EP0969819B1 (fr) 1998-11-10 1998-11-10 Nouvelle forme cristalline d'omeprazole
CA002363810A CA2363810A1 (fr) 1998-11-10 1998-11-10 Nouvelle forme d'omeprazole
US10/076,225 US20020156284A1 (en) 1998-11-10 2002-02-13 Crystalline form of omeprazole

Publications (1)

Publication Number Publication Date
ZA9811174B true ZA9811174B (en) 2000-06-07

Family

ID=27543202

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811174A ZA9811174B (en) 1998-11-10 1998-12-07 New crystalline form of omeprazole.

Country Status (34)

Country Link
US (3) US6150380A (fr)
EP (2) EP0969819B1 (fr)
JP (1) JP3457945B2 (fr)
CN (1) CN1347413A (fr)
AT (1) ATE233755T1 (fr)
AU (1) AU756434B2 (fr)
BR (1) BR9816067A (fr)
CA (2) CA2284470C (fr)
CZ (1) CZ301635B6 (fr)
DE (3) DE69811868T2 (fr)
DK (2) DK0969819T3 (fr)
DZ (1) DZ2669A1 (fr)
EE (1) EE04279B1 (fr)
ES (1) ES2139559T3 (fr)
FI (1) FI3873U1 (fr)
GR (1) GR990300034T1 (fr)
HK (1) HK1024242A1 (fr)
HR (1) HRP20010281B1 (fr)
HU (1) HUP0104379A3 (fr)
IL (1) IL142703A0 (fr)
IS (1) IS2025B (fr)
MA (1) MA26574A1 (fr)
NO (1) NO320014B1 (fr)
NZ (1) NZ511377A (fr)
PL (1) PL190870B1 (fr)
PT (1) PT969819E (fr)
RU (1) RU2207339C2 (fr)
SI (1) SI0969819T1 (fr)
SK (1) SK286562B6 (fr)
TR (1) TR200101282T2 (fr)
TW (1) TW533203B (fr)
UA (1) UA72748C2 (fr)
WO (1) WO1999008500A2 (fr)
ZA (1) ZA9811174B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SI20019A (sl) 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
IL142703A (en) * 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6750064B2 (en) * 2000-12-28 2004-06-15 S.S.C.I. Inc. Methods of screening for possible solid forms
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
US7855082B1 (en) 2001-10-31 2010-12-21 Astrazeneca Ab Raman spectroscopic method for determining the ratio of 5-methoxy and 6-methoxy isomers of omeprazole
WO2004072061A1 (fr) 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Procede de stabilisation de lansoprazole
ES2245277T1 (es) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7892354B2 (en) * 2003-10-06 2011-02-22 Solvias Ag Process for the parallel detection of crystalline forms of molecular solids
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2006073779A1 (fr) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Nouvelles formes de l'omeprazole et méthodes correspondantes
US8247566B2 (en) * 2005-06-08 2012-08-21 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
EP1904064A4 (fr) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr Omeprazole de forme b
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
WO2008067037A2 (fr) 2006-10-05 2008-06-05 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
EP2086543A2 (fr) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
WO2008092939A2 (fr) 2007-01-31 2008-08-07 Krka, Tovarna Zdravil, D.D., Novo Mesto Procédé de préparation d'oméprazole optiquement pur
US20090010388A1 (en) * 2007-06-06 2009-01-08 Stahly Barbara C Microplate and methods of using the same
US8018588B2 (en) * 2007-06-06 2011-09-13 Aptuit, Inc. Sample holder and sample preparation device
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids
WO2009137648A1 (fr) * 2008-05-09 2009-11-12 Aptapharma, Inc. Pastilles multicouches inhibant la pompe à protons
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
WO2010134099A1 (fr) 2009-05-21 2010-11-25 Cadila Healthcare Limited Procédé de préparation dans un récipient unique d'oméprazole
WO2011054783A2 (fr) * 2009-11-03 2011-05-12 Glaxo Group Limited Nouveaux procédés
GB201001075D0 (en) 2010-01-22 2010-03-10 Cyclacel Ltd Crystalline forms
RU2501549C1 (ru) 2012-08-30 2013-12-20 Авва Девелопмент Лтд Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
RU2726320C1 (ru) * 2020-02-09 2020-07-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) Способ определения примесных компонентов омепразола
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
IE67187B1 (en) 1990-06-15 1996-03-06 Merck & Co Inc A crystallization method to improve crystal structure and size
US5877192A (en) * 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
US5714505A (en) * 1994-01-05 1998-02-03 Astra Aktiebolag Method for treatment of psoriasis, by omeprazole or related compounds
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
TW385306B (en) 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process

Also Published As

Publication number Publication date
US6384059B1 (en) 2002-05-07
CZ20011611A3 (cs) 2002-01-16
NZ511377A (en) 2003-04-29
IS5935A (is) 2001-05-07
AU756434B2 (en) 2003-01-16
HUP0104379A2 (hu) 2002-04-29
CZ301635B6 (cs) 2010-05-12
WO1999008500A2 (fr) 1999-02-25
DE69811868T2 (de) 2004-03-04
PT969819E (pt) 2003-06-30
US20020156284A1 (en) 2002-10-24
TW533203B (en) 2003-05-21
MA26574A1 (fr) 2004-12-20
CA2363810A1 (fr) 1999-02-25
WO1999008500A3 (fr) 1999-07-29
EP1221314A1 (fr) 2002-07-10
IL142703A0 (en) 2002-03-10
IS2025B (is) 2005-08-15
PL190870B1 (pl) 2006-02-28
CN1347413A (zh) 2002-05-01
DE69811868D1 (de) 2003-04-10
SI0969819T1 (en) 2003-06-30
ES2139559T3 (es) 2003-10-01
TR200101282T2 (tr) 2001-11-21
HRP20010281A2 (en) 2002-06-30
BR9816067A (pt) 2001-08-07
EP0969819B1 (fr) 2003-03-05
HK1024242A1 (en) 2000-10-05
NO20012286D0 (no) 2001-05-09
CA2284470A1 (fr) 1999-02-25
AU1355199A (en) 1999-03-08
NO320014B1 (no) 2005-10-10
SK5452001A3 (en) 2001-11-06
PL348247A1 (en) 2002-05-20
DE969819T1 (de) 2000-04-06
EP0969819A2 (fr) 2000-01-12
EE04279B1 (et) 2004-04-15
US6150380A (en) 2000-11-21
CA2284470C (fr) 2002-02-26
HUP0104379A3 (en) 2003-01-28
ES2139559T1 (es) 2000-02-16
ATE233755T1 (de) 2003-03-15
RU2207339C2 (ru) 2003-06-27
DZ2669A1 (fr) 2003-03-22
HRP20010281B1 (en) 2004-04-30
UA72748C2 (en) 2005-04-15
DE29823393U1 (de) 1999-05-27
DK199900074U1 (da) 2000-02-10
FI3873U1 (fi) 1999-03-22
JP3457945B2 (ja) 2003-10-20
SK286562B6 (sk) 2009-01-07
FIU980578U0 (fi) 1998-12-21
GR990300034T1 (en) 2000-07-31
JP2001522780A (ja) 2001-11-20
DK0969819T3 (da) 2003-05-19
NO20012286L (no) 2001-07-03
EE200100248A (et) 2002-10-15

Similar Documents

Publication Publication Date Title
GR990300034T1 (en) New crystalline form of omeprazole
SE9702483D0 (sv) New compound
CA2357744A1 (fr) Sel de potassium, de (s)-omeprazole
CA2290963A1 (fr) Trihydrate de magnesium s-omeprazole
WO2002017358A3 (fr) Fractions heteroaryle substituees par quinuclidine destinees au traitement de maladies
ZA989999B (en) New process for the preparation of 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)1H-benzimidazole
MY118724A (en) New crystalline form of omeprazole
YU32301A (sh) Novi kristalni oblik omeprazola
MXPA05009183A (es) Polimorfos de s-omeprazol.